Walleye Trading
SCPH

Walleye Trading’s scPharmaceuticals SCPH Stock Holding History

Walleye Trading’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32,608
Closed -$204K – 5594
2023
Q4 		$204K Buy
32,608
+19,075
+141% +$109K ﹤0.01% 3770
2023
Q3 		$96.4K Sell
13,533
-18,631
-58% -$147K ﹤0.01% 3982
2023
Q2 		$328K Buy
+32,164
New +$336K 0.02% 3100
2020
Q3 		– Sell
-10,424
Closed -$77K – 5031
2020
Q2 		$77K Buy
+10,424
New +$91.6K ﹤0.01% 3639

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
JGC
J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return